- Release Date: 10/07/23 09:17
- Summary: NTI Receives HREC Approval for Rett Syndrome Clinical Trial
- Price Sensitive: Yes
- Download Document 213.2KB
- Forums
- ASX - By Stock
- Ann: NTI Receives HREC Approval for Rett Syndrome Clinical Trial
Ann: NTI Receives HREC Approval for Rett Syndrome Clinical Trial
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NTI (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.8¢ |
Change
-0.002(4.00%) |
Mkt cap ! $49.66M |
Open | High | Low | Value | Volume |
5.0¢ | 5.0¢ | 4.8¢ | $30.91K | 632.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 445029 | 4.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.9¢ | 50000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 445029 | 0.048 |
6 | 1235489 | 0.047 |
4 | 1728152 | 0.046 |
3 | 147240 | 0.045 |
1 | 22000 | 0.044 |
Price($) | Vol. | No. |
---|---|---|
0.049 | 50000 | 1 |
0.050 | 100000 | 1 |
0.051 | 409998 | 2 |
0.053 | 80000 | 1 |
0.054 | 63420 | 1 |
Last trade - 15.56pm 16/10/2024 (20 minute delay) ? |
Featured News
NTI (ASX) Chart |
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non Executive Director
Simon Kidston
Non Executive Director
Previous Video
Next Video
SPONSORED BY The Market Online